InspireMD Inc. - Common Stock (NQ:NSPR)

0.5900 -0.0300 (-4.84%)

Delayed Quote Updated: 11:52 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about InspireMD Inc. - Common Stock

< Previous 1 2 3 Next >

5 Penny Stocks Insiders Are Buying ↗

November 24, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 23, 2021

Gainers Biolase (NASDAQ:BIOL) shares incr...

Via Benzinga

50 Biggest Movers From Yesterday ↗

October 14, 2021

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating...

Via Benzinga

Earnings Scheduled For August 10, 2021 ↗

August 10, 2021

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Earnings Scheduled For May 11, 2021 ↗

May 11, 2021

Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is...

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

October 13, 2021

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; JPMorgan Posts Upbeat Earnings ↗

October 13, 2021

Following the market opening Wednesday, the Dow traded down 0.36% to 34,254.62 while the NASDAQ rose 0.27% to 14,505.47. The S&P also fell, dropping 0.07% to 4,347.49. The U.S...

Via Benzinga

Topics Stocks

3 Penny Stocks Insiders Are Buying ↗

August 27, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

PreMarket Prep Stock Of The Day: InspireMD ↗

April 27, 2021

Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast...

Via Benzinga

60 Biggest Movers From Friday ↗

August 30, 2021

Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share. Navios Maritime Acquisition...

Via Benzinga

InspireMD Reports Narrower Loss In Q2 As Revenue Rebounds On Procedural Recovery ↗

August 10, 2021

InspireMD Inc (NASDAQ: NSPR) has recorded a robust increase in second-quarter FY21 sales of $1.04 million, +231.6% Y/Y, slightly missing the consensus of $1.1...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 10, 2021

Gainers Arcturus Therapeutics (NASDAQ:ARCT) shares rose 25.93% to $60.75 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.5...

Via Benzinga

61 Biggest Movers From Yesterday ↗

July 23, 2021

Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy...

Via Benzinga

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗

July 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

July 22, 2021

Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 22, 2021

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 53.01% to $15.47 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume...

Via Benzinga

21 Stocks Moving in Thursday's Pre-Market Session ↗

July 22, 2021

Gainers PainReform Ltd (NASDAQ: PRFX) shares rose 123% to $7.00 in pre-market trading. Second Sight Medical Products Inc (NASDAQ: EYES) shares rose 29% to $5.57 in pre-market...

Via Benzinga

61 Biggest Movers From Yesterday ↗

July 22, 2021

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a $28.3 million purchase order from Brazil's...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 21, 2021

Gainers Second Sight Medical (NASDAQ:EYES

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

July 21, 2021

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 08, 2021

Gainers Aytu BioPharma (NASDAQ:AYTU) stock increased by 19.36% to $6.41 during Tuesday's pre-market session. The market value of their outstanding shares is at $161.3...

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

April 27, 2021

Gainers RiceBran Technologies (NASDAQ: RIBT) shares jumped 60.8% to $1.4950. RiceBran Technologies is scheduled to host a conference call on April 28th to discuss its Q1...

Via Benzinga

58 Biggest Movers From Yesterday ↗

May 19, 2021

Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results. Ultralife Corporation (NASDAQ: ULBI)...

Via Benzinga

24 Stocks Moving in Tuesday's Pre-Market Session ↗

April 27, 2021

Gainers RiceBran Technologies (NASDAQ: RIBT) shares rose 29.1% to $1.20 in pre-market trading. RiceBran Technologies is scheduled to host a conference call on April 28th to...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

56 Stocks Moving In Friday's Mid-Day Session ↗

May 07, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321. Regional Health Properties, Inc. (NYSE: RHE) gained 43% to $21.40 after dropping 23% on Thursday....

Via Benzinga

21 Stocks Moving in Monday's Pre-Market Session ↗

April 26, 2021

Gainers Ocugen, Inc. (NASDAQ: OCGN) shares rose 20.6% to $11.61 in pre-market trading. Ocugen’s COVID-19 vaccine partner, India-based Bharat Biotech International Ltd.,...

Via Benzinga

46 Biggest Movers From Yesterday ↗

April 21, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares jumped 27.3% to close at $9.79 on Tuesday after the company reported inducement grants. The company recently said it...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.